Healx to receive investment from Children’s Tumor Foundation to advance Neurofibromatosis Type 1 treatments
Cambridge, UK - Healx, the AI-powered, patient-inspired, techbio company pioneering the next generation of drug discovery, announces that it has signed an investment agreement with its long-term partner,
Metrion Biosciences enhances High Throughput Screening services with access to Enamine compound libraries
Access to compound collection enables greater flexibility and efficiencies in screening and target identification
Versius launches in Portugal as at Lusíadas Group hospital start surgical cases
CMR Surgical (CMR) – the global surgical robotics business, announces the introduction of its next-generation Surgical Robotic System, Versius, at Hospital Lusíadas Porto, marking the first installation of Versius in Portugal.
Introducing Timestrip neo Multi
Timestrip Introduces World’s First Multiple Use Temperature Indicator. Timestrip has introduced what is believed to be the first multiple-use temperature indicator of its kind available.
Preci and Biopredic International partner for higher performance of suspended pooled hepatocytes with extended longevity and large-scale availability
License agreement extends access to culture-stable pooled hepatocyte cell models with increased longevity for use in DMPK and ADME studies
Young heroes from The Regis School help transform children’s health research
In collaboration with our partners at leading mental health charity Anna Freud, D-CYPHR held a learning event at the West Sussex secondary school, listening to pupils’ ideas around children’s rights to good health and highlighting different ways they can make a positive impact.
COVID-19 BioResource participants in new study identifying key trigger of long COVID
Volunteer data from our COVID-19 BioResource has been used in a new study, published by Nature Immunology, which discovered that problems with iron levels in the blood and the body’s ability to regulate this important nutrient as a result of SARS-CoV-2 infection could be a key trigger for long COVID.
Cambridge Future Tech expands its Board with the appointment of Michael Beer and Jem Davies as Non-Executive Directors
Leading deeptech venture-builder further strengthens its unique position to cultivate innovative technologies with the addition of seasoned industry professionals
Have you heard about Carers Leave?
From 6 April 2024 all unpaid carers are entitled to up to a week's unpaid leave per year to look after someone with a disability or long-term illness. But don't panic! We are here to help :-)
Understanding and managing Interstitial Lung Disease
Interstitial lung disease (ILD) is an umbrella term used to describe a group of highly variable restrictive lung diseases, which are characterised by inflammation and pulmonary fibrosis (scarring of the lungs).
Bio-Rad and Allegheny Health Network Cancer Institute collaborate to advance personalised monitoring of solid tumor cancers with Droplet Digital PCR
Collaboration aims to grow clinical evidence supporting the use of Bio-Rad’s ddPCR™ technology for molecular residual disease monitoring of patients across a range of solid tumor types.
Nxera Pharma joins the World Orphan Drug Alliance
Tokyo, Japan and Cambridge, UK, 8 April 2024 – Nxera Pharma Co. Ltd, formerly known as Sosei Group or Sosei Heptares – announces it has joined the World Orphan Drug Alliance (WODA), a global alliance of commercial distributors dedicated to providing access to treatments for rare diseases and specialty medicines in complex markets around the world. The Alliance consists of 12 member companies and…
Roll out of Cambridge-developed artificial pancreas is world first
An artificial pancreas developed with the help of staff and patients at Addenbrooke’s Hospital is one of four new devices to be rolled out by the NHS – helping tens of thousands of children and adults living with type one diabetes.
Guardtech Group ready to spring into action with another string of exhibitions
Suffolk-based cleanroom construction specialists line up four massive shows in April, May and June
GLAD Study opens recruitment for participants without history of mental health condition
The Genetic Links to Anxiety and Depression (GLAD) Study, part of our Mental Health BioResource, is thrilled to announce the launch of a recruitment drive for individuals without a history of anxiety and depression. In a world where millions are affected by mental health struggles like anxiety and depression, it is crucial to understand more about the complex web of genetic and environmental…
Sookio launches podcast, Communication Untangled
Join host Sue Keogh and guests from the worlds of design, communications, and behavioural psychology for Communication Untangled – a new podcast exploring the many facets of communication that influence our behaviour, but often go unnoticed.
Researchers report findings to improve medication management in palliative care
A study led by CPFT experts reviewing how medications are used in palliative care to support patients in the community has been published in a leading international nursing journal.
Bio-Rad launches first Ultrasensitive Multiplexed Digital PCR Assay for breast cancer mutation detection in clinical research
Highly Sensitive and Multiplexed Assay for the Detection, Discrimination, and Quantification of Key Mutations in ESR1 Gene for Breast Cancer, Developed for Bio-Rad’s QX600™ Droplet Digital™ PCR System
GlucoTrack announces increased sensor longevity for its implantable Continuous Blood Glucose Monitor
Rutherford, NJ & Cambridge, UK, April 2, 2024 (GLOBE NEWSWIRE) — GlucoTrack, Inc., a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, and The Technology Partnership (“TTP”), today announced the completion of compu
UK's only research institute dedicated to understanding early cancer receives £11 million donation
The University of Cambridge’s Early Cancer Institute – the UK's only research facility dedicated to understanding early cancer – has received a landmark £11 million donation to support its vital work in the fight against cancer.
News Science Human Genetics Single genomic test promises accelerated diagnoses for rare genetic diseases
A single genetic test could potentially replace the current two-step approach to diagnosing rare developmental disorders in children. This shift could enable earlier diagnoses for families and save the NHS vital resources.
Digital Biomarkers: capturing real-world patient journeys to advance care
Digital biomarkers hold great promise in advancing patient care through improved patient monitoring.
Advanced Threat Group (ATG) & CyberScale Strategic Alliance
On 1st April 2024 CyberScale and Advanced Threat Group (ATG) formally recognised a strategic alliance aimed at providing their clients with an optimal combination of strategic advice and technical support around Cyber & Information Security.
Abzena announces major investment in Bioconjugation and ADC capabilities
Abzena announces major investment in Bioconjugation and ADC capabilities in response to increasing industry demand.
Walk for Hospice Care – Star Shine Night Walk is back in Cambridge!
A celebratory sunset walk on Saturday 22 June for adult hospice care.